News
Arista Networks (NYSE:ANET) reported a very strong second quarter and announced guidance for the 3rd quarter, both of which were ahead of FactSet consensus....
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
First Bank (NASDAQ:FRBA) Q4 2024 Results Conference Call January 24, 2025 9:00 AM ET Company Participants Patrick Ryan – President and Chief Executive OfficerAndrew...
News
Origin Bancorp, Inc. (NYSE:OBK) Q4 2024 Results Conference Call January 23, 2025 9:00 AM ET Company Participants Chris Reigelman – Director, Investor RelationsDrake Mills...
News
This article was written by Follow Knox Ridley began consulting on portfolios in 2007 and is an experienced growth investor in both bull and...
News
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands...
News
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Ray Furey – EVP, General Counsel and...
News
Cardlytics, Inc. (NASDAQ:CDLX) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Nick Lynton – Chief, Legal and Privacy Officer...
News
V.F. Corporation (NYSE:VFC) Q1 2024 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Allegra Perry – Vice President, Investor Relations Bracken...
News
“‘We want to let the country know that some people want to do something about this, and others don’t want to do something about...
News
Alsea, S.A.B. de C.V. (OTCPK:ALSSF) Q2 2023 Earnings Call Transcript July 27, 2023 10:00 AM ET Company Participants Nicolás Espinoza Meneses – IR Armando...
News
IQVIA Holdings Inc. (NYSE:IQV) Q2 2023 Earnings Conference Call August 1, 2023 9:00 AM ET Company Participants Nick Childs – SVP, IR and Treasurer...
News
Tipping has hit the tipping point for many Americans. “Tipflation” is a term on everyone’s lips and fingertips this summer as both tip amounts...
News
Introduction TG Therapeutics, Inc. (NASDAQ:TGTX) develops and markets treatments for B-cell malignancies and autoimmune diseases. Their FDA-approved product, Briumvi, is a monoclonal antibody therapy...
